1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > General Medicine and Specialty Medicine Analysis & Statistics, August 2016 (p5)

General Medicine and Specialty Medicine Analysis & Statistics, August 2016 (p5)

24/7 Customer Support

Talk to Veronica

+44 207 0971 241

Publishers

All regions

121-150 of about 3 200 reports

Purchase Reports From Reputable Market Research Publishers

Europe Bariatric Surgery Market - Mordor Intelligence

Europe Bariatric Surgery Market - Mordor Intelligence

  • € 3 080
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Europe Bariatric Surgery Market has been estimated at USD 514.5 million in 2015 and is projected to reach USD 977.9 million by 2020. Bariatric surgery includes a range of procedures to be performed ...

  • Industries : General Medicine and Specialty Medicine, Medical Device, Healthcare
  • Countries : Europe
Middle East CT Market - Growth, Trends And Forecasts (2015 - 2020)

Middle East CT Market - Growth, Trends And Forecasts (2015 - 2020)

  • € 3 080
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Middle East & Africa CT Scanners market is poised to reach $XX billion by the end of 2020 growing at a CAGR of XX%.Computed tomography (CT) is an imaging process that customs special x-ray equipment ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : Africa
Europe Telemedicine Market – Growth, Trends And Forecasts (2015-2020)

Europe Telemedicine Market – Growth, Trends And Forecasts (2015-2020)

  • € 3 080
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Europe Telemedicine Market has been estimated to be USD XX billion in 2015 and it is projected to reach USD XX billion by 2020 at a CAGR of XX% during the forecast period from 2015 to 2020. Telemedicine ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : Europe
World Nuclear Medicine/Radiopharmaceuticals Market - Opportunities and Forecasts, 2014 - 2022

World Nuclear Medicine/Radiopharmaceuticals Market - Opportunities and Forecasts, 2014 - 2022

  • € 3 072
  • Industry report
  • July 2016
  • by Allied Market Research

Radiopharmaceuticals are pharmaceutical formulations comprising radioactive isotopes that are used in diagnosis and therapeutics. They are simple and small substances that contain a radioactive substance ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : World
World Nuclear Medicine/Radiopharmaceuticals Market - Opportunities and Forecasts, 2014 - 2022

World Nuclear Medicine/Radiopharmaceuticals Market - Opportunities and Forecasts, 2014 - 2022

  • € 3 072
  • Industry report
  • July 2016
  • by Allied Market Research

Radiopharmaceuticals are pharmaceutical formulations comprising radioactive isotopes that are used in diagnosis and therapeutics. They are simple and small substances that contain a radioactive substance ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : World
Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016

Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016

  • € 2 800
  • Company report
  • August 2016
  • by Global Markets Direct

Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016 Summary Global Markets ...

  • Industries : Pharmaceutical, Pathology
  • Countries : United States
Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) - Pipeline Review, H2 2016

Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) - Pipeline Review, H2 2016

  • € 2 800
  • Company report
  • August 2016
  • by Global Markets Direct

Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy
  • Countries : United States
Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity Nerve Growth Factor Receptor or Gp80 LNGFR or p75 ICD or TNFRSF16 or CD271 or NGFR) - Pipeline Review, H2 2016

Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity Nerve Growth Factor Receptor or Gp80 LNGFR or p75 ICD or TNFRSF16 or CD271 or NGFR) - Pipeline Review, H2 2016

  • € 2 800
  • Company report
  • August 2016
  • by Global Markets Direct

Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity Nerve Growth Factor Receptor or Gp80 LNGFR or p75 ICD or TNFRSF16 or CD271 or NGFR) - Pipeline ...

  • Industries : Therapy, Pathology
  • Countries : Italy, World, Europe
Peptidyl Prolyl Cis Trans Isomerase D (40 kDa Peptidyl Prolyl Cis Trans Isomerase or Cyclophilin 40 or Cyclophilin D or Rotamase D or PPID or EC 5.2.1.8) - Pipeline Review, H2 2016

Peptidyl Prolyl Cis Trans Isomerase D (40 kDa Peptidyl Prolyl Cis Trans Isomerase or Cyclophilin 40 or Cyclophilin D or Rotamase D or PPID or EC 5.2.1.8) - Pipeline Review, H2 2016

  • € 2 800
  • Company report
  • August 2016
  • by Global Markets Direct

Peptidyl Prolyl Cis Trans Isomerase D (40 kDa Peptidyl Prolyl Cis Trans Isomerase or Cyclophilin 40 or Cyclophilin D or Rotamase D or PPID or EC 5.2.1.8) - Pipeline Review, H2 2016 Summary Global Markets ...

  • Industries : Pharmaceutical, Therapy
  • Countries : World
US Cardiovascular Devices Pipeline Product Analysis - Stage, Indication and Estimated Approval Date

US Cardiovascular Devices Pipeline Product Analysis - Stage, Indication and Estimated Approval Date

  • € 2 800
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Cardiovascular Devices are used to diagnose and treat heart diseases and related health problems. This report provides Pipeline Analysis of the Cardiovascular Devices in the United States region. This ...

  • Industries : Cardiovascular Devices, Medical Device
  • Countries : United States
Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2016

Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2016

  • € 2 800
  • Company report
  • July 2016
  • by Global Markets Direct

Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Pharmaceutical, Therapy
  • Countries : United States
Vascular Endothelial Growth Factor B (VEGF Related Factor or VEGFB) - Pipeline Review, H2 2016

Vascular Endothelial Growth Factor B (VEGF Related Factor or VEGFB) - Pipeline Review, H2 2016

  • € 2 800
  • Company report
  • July 2016
  • by Global Markets Direct

Vascular Endothelial Growth Factor B (VEGF Related Factor or VEGFB) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Vascular Endothelial Growth Factor B (VEGF Related Factor or VEGFB) ...

  • Industries : Therapy, Pathology
  • Countries : United States, World
Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025

  • € 2 800
  • Industry report
  • July 2016
  • by Kalorama Information

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025 examines the leaders in the pharmaceutical industry, including the late-term pipeline of major companies. This report provides ...

  • Industries : Pharmaceutical
  • Countries : United States, World
Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H2 2016

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H2 2016

  • € 2 800
  • Company report
  • July 2016
  • by Global Markets Direct

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Integrin Beta 1 (Fibronectin ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical, Drug Discovery and Development
  • Countries : World
High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk or p140 TrkA or NTRK1 or EC 2.7.10.1) - Pipeline

High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk or p140 TrkA or NTRK1 or EC 2.7.10.1) - Pipeline

  • € 2 800
  • Industry report
  • July 2016
  • by Global Markets Direct

High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States
Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2016

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2016

  • € 2 800
  • Company report
  • July 2016
  • by Global Markets Direct

Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2016’, provides in depth analysis on Toll ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : United States, Europe, World
NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H1 2016

NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H1 2016

  • € 2 800
  • Company report
  • June 2016
  • by Global Markets Direct

NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘NT ...

  • Industries : Cancer, Pathology
  • Countries : United States
RAF Proto-Oncogene Serine/Threonine-Protein Kinase (C-Raf Kinase or Proto-Oncogene c-RAF or Raf-1 or EC 2.7.11.1) - Pipeline Review, H1 2016

RAF Proto-Oncogene Serine/Threonine-Protein Kinase (C-Raf Kinase or Proto-Oncogene c-RAF or Raf-1 or EC 2.7.11.1) - Pipeline Review, H1 2016

  • € 2 800
  • Company report
  • June 2016
  • by Global Markets Direct

RAF Proto-Oncogene Serine/Threonine-Protein Kinase (C-Raf Kinase or Proto-Oncogene c-RAF or Raf-1 or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘RAF Proto-Oncogene Se ...

  • Industries : Therapy, Cancer, Pathology
  • Countries : United States
BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H1 2016

BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H1 2016

  • € 2 800
  • Company report
  • June 2016
  • by Global Markets Direct

BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H1 2016 ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H1 2016

Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H1 2016

  • € 2 800
  • Company report
  • June 2016
  • by Global Markets Direct

Potassium Voltage Gated Channel Subfamily KQT Member 2 (Neuroblastoma Specific Potassium Channel Subunit Alpha KvLQT2 or Voltage Gated Potassium Channel Subunit Kv7.2 or KCNQ2) - Pipeline Review, H1 2016 ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Serine/Threonine-Protein Kinase A-Raf (A-Raf Kinase or Proto-Oncogene A-Raf or Proto-Oncogene Pks or EC 2.7.11.1) - Pipeline Review, H1 2016

Serine/Threonine-Protein Kinase A-Raf (A-Raf Kinase or Proto-Oncogene A-Raf or Proto-Oncogene Pks or EC 2.7.11.1) - Pipeline Review, H1 2016

  • € 2 800
  • Company report
  • June 2016
  • by Global Markets Direct

Serine/Threonine-Protein Kinase A-Raf (A-Raf Kinase or Proto-Oncogene A-Raf or Proto-Oncogene Pks or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Serine/Threonine-Protein ...

  • Industries : Therapy, Cancer, Biopharmaceutical, Pathology
  • Countries : United States, World
Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H1 2016

Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H1 2016

  • € 2 800
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H1 2016 Summary Global ...

  • Industries : Pathology, Therapy, Biological Therapy, Biotechnology
  • Countries : United States
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF-2 or bFGF) - Pipeline Review, H1 2016

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF-2 or bFGF) - Pipeline Review, H1 2016

  • € 2 800
  • Company report
  • June 2016
  • by Global Markets Direct

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF-2 or bFGF) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Fibroblast Growth Facto ...

  • Industries : Therapy, Pathology, Cancer, Pharmaceutical
  • Countries : United States, World
Placental Growth Factor (PIGF or Vascular Endothelial Growth Factor Related Protein) - Pipeline Review, H1 2016

Placental Growth Factor (PIGF or Vascular Endothelial Growth Factor Related Protein) - Pipeline Review, H1 2016

  • € 2 800
  • Company report
  • June 2016
  • by Global Markets Direct

Placental Growth Factor (PIGF or Vascular Endothelial Growth Factor Related Protein) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Placental Growth Factor (PIGF or Vascular Endothelial ...

  • Industries : Therapy, Biopharmaceutical, Pathology, Pharmaceutical
  • Countries : United States, World
Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H1 2016

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H1 2016

  • € 2 800
  • Company report
  • June 2016
  • by Global Markets Direct

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H1 2016’, provides ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : World, United States, Europe
Global Central Nervous System Partnering 2010-2016: Deal trends, players and financials

Global Central Nervous System Partnering 2010-2016: Deal trends, players and financials

  • € 2 796
  • Industry report
  • September 2016
  • by Currentpartnering

Global Central Nervous System Partnering 2010 to 2016 provides the full collection of Central Nervous System disease deals signed between the world’s pharmaceutical and biotechnology companies since ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : World
Global Hospital Care Partnering 2010-2016: Deal trends, players and financials

Global Hospital Care Partnering 2010-2016: Deal trends, players and financials

  • € 2 796
  • Industry report
  • September 2016
  • by Currentpartnering

Global Hospital Care Partnering 2010 to 2016 provides the full collection of Hospital Care disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010. Trends in Hospital ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : World
Global Oncology Partnering 2010-2016: Deal trends, players and financials

Global Oncology Partnering 2010-2016: Deal trends, players and financials

  • € 2 796
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Oncology Partnering 2010-2016: Deal trends, players and financials report provides an understanding and access to the oncology partnering deals and agreements entered into by the worlds leading ...

  • Industries : Cancer, Pathology, General Medicine and Specialty Medicine
  • Countries : World
Eyewear Market - Middle East Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Eyewear Market - Middle East Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

  • € 2 716
  • Industry report
  • July 2016
  • by Transparency Market Research

Eyewear consists of products used to aid in vision correction, cosmetic enhancement and protection of the eyes.Corrective eyewear can be used to correct and alleviate refractive errors. Spectacles and ...

  • Industries : General Medicine and Specialty Medicine
South Korea Medical Aesthetic Devices Market - Growth, Trends and Forecasts (2015 - 2020)

South Korea Medical Aesthetic Devices Market - Growth, Trends and Forecasts (2015 - 2020)

  • € 2 400
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

South Korea’s Aesthetic Medical Devices Market accounted for a share of US$ 389 million in 2015. It is expected to reach US$ 948 million by 2020, at a CAGR of 19.5% from 2015 to 2020. North America currently ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : South Korea

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.